切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2022, Vol. 16 ›› Issue (04) : 325 -330. doi: 10.3877/cma.j.issn.1674-3253.2022.04.009

临床研究

儿童机器人辅助腹腔镜下Xp11.2易位/TFE3基因融合相关性肾癌根治术的初步探讨
吕逸清1, 谢华1,(), 周立军1, 陈艳1, 汪亚平1, 陈方1   
  1. 1. 200062 上海市儿童医院,上海交通大学附属儿童医院泌尿外科
  • 收稿日期:2021-05-10 出版日期:2022-08-01
  • 通信作者: 谢华

Robotic-assisted laparoscopic radical nephrectomy for pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion

Yiqing Lyu1, Hua Xie1,(), Lijun Zhou1, Yan Chen1, Yaping Wang1, Fang Chen1   

  1. 1. Department of Urology, Shanghai Children’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200062, China
  • Received:2021-05-10 Published:2022-08-01
  • Corresponding author: Hua Xie
引用本文:

吕逸清, 谢华, 周立军, 陈艳, 汪亚平, 陈方. 儿童机器人辅助腹腔镜下Xp11.2易位/TFE3基因融合相关性肾癌根治术的初步探讨[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(04): 325-330.

Yiqing Lyu, Hua Xie, Lijun Zhou, Yan Chen, Yaping Wang, Fang Chen. Robotic-assisted laparoscopic radical nephrectomy for pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion[J]. Chinese Journal of Endourology(Electronic Edition), 2022, 16(04): 325-330.

目的

探讨儿童机器人辅助腹腔镜下Xp11.2易位/TFE3基因融合相关性肾癌根治术的安全及疗效性。

方法

回顾性分析2017至2019年我院采用机器人辅助腹腔镜下对Xp11.2易位型肾癌患儿行肾癌根治术的临床资料,并结合国内外文献对本病的流行病学特点、临床表现、病理、影像及治疗和预后进行总结分析。

结果

2例患儿,年龄分别为4岁5个月及6岁3个月,男性、女性各1例,主诉均为无痛性肉眼血尿,超声、CT及磁共振提示左肾占位。通过机器人辅助腹腔镜下完成根治性肾切除手术,未中转开放。术后病理检查报告肿瘤剖面灰黄色,质软,主要由透明细胞组成,瘤细胞伴有嗜酸性颗粒胞浆,组成巢状结构,透明变性的结节内可见散在砂粒体。免疫组化显示TEF3(+),CD10(+),CK(-),WT1(-),Vimentin(-),EMA(-),Ki-67(+2%),Bcl-2(+),CD34(-),S100(-),DES(-),CD99(-),INI-1(+),符合Xp11.2易位型肾癌。术后给予定期随访,未见肿瘤复发及转移。

结论

机器人辅助腹腔镜下肾癌根治术可以安全、有效地应用于儿童早期Xp11.2易位型肾癌的治疗。

Objective

To evaluate the feasibility and outcomes of robotic-assisted laparoscopic radical nephrectomy for pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.

Methods

A retrospective study was performed of patients who underwent robotic assisted laparoscopic approach for renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion at our institution between 2017 to 2019. The epidemiological character, clinical data, histologic findings, image data and outcomes of these cases were reviewed together with the related literatures.

Results

A 4-year-old girl and a 6-year-old boy with gross hematuria were diagnosed with left renal tumor by ultrasound, CT and MRI. Two patients underwent robotic assisted laparoscopic radical nephrectomy without conversion to open surgery. Grossly, The tumor was soft and the cut surface was brown. Microscopically, the tumor predominantly composed of clear cells. The tumor cells were rich of eosinophilic granular cytoplasm. Immunohistochemically, the tumor cells displayed as TEF3(+), CD10(+), CK(-), WT1(-), Vimentin(-), EMA(-), Ki-67(+2%), Bcl-2(+), CD34(-), S100(-), DES(-), CD99(-) and INI-1(+). The pathological diagnosis was renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion. There was no perioperative complications, and all patients were survived without recurrence or metastasis during the follow-up period.

Conclusions

Robotic assisted laparoscopic radical nephrectomy can be safely and effectively performed on early staged pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.

图1~9 肾癌患儿术前影像学资料、术中术后照片及病理注:图1为术前彩超,图2为术前CT,图3为术前MR,图4为阻断左肾动脉,图5为阻断左肾静脉,图6~7术后标本大体观及剖面观,图8为病理TFE3染色100×,红色箭头所指均为TFE3染色阳性的肿瘤细胞,图9为病理HE染色40×,黄色框内为特征性的透明细胞组成的巢状结构
表1 两例肾癌患儿临床资料
表2 两例肾癌患儿手术具体资料
表3 Xp11.2易位型肾癌亚型[5]
[1]
Eble JN, Sauter G, Epstein JI, et al. World Health Organization classification of turnouts: pathology and genetics of tumours of the urinary system and male genital organs[M]. IARC Press, Lyon, 2004: 37-38.
[2]
周立军,谢华,陈方,等. 隐蔽切口法在机器人辅助腹腔镜下儿童肾肿瘤根治术标本取出中的应用体会[J]. 中华小儿外科杂志, 2020, 41(3): 201-204.
[3]
Cost NG, Liss ZJ, Bean CM, et al. Prechemotherapy robotic-assisted laparoscopic radical nephrectomy for an adolescent with Wilms tumor[J]. J Pediatr Hematol Oncol, 2015, 37(2): e125-e127.
[4]
Armah HB, Parwani AV, Surti U, et al. Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature[J]. Diagn Pathol, 2009, 4(1): 1-11.
[5]
Calio A, Segala D, Munari E, et al. MiT family translocation renal cell carcinoma: from the early descriptions to the current knowledge[J]. Cancers (Basel), 2019, 11(8): 1110.
[6]
Argani, P, Reuter VE, Zhang L, et al. TFEB-amplified renal cell carcinomas: an aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity[J]. Am J Surg Pathol, 2016. 40(11): 1484-1495.
[7]
Klatte T, Streubel B, Wrba F, et al. Renal cell carcinoma associated with transcription factor e3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis[J]. Am J Clin Pathol, 2012, 137(5): 761-768.
[8]
Su HH, Sung MT, Chiang PH, et al. The preliminary experiences of translocation renal cell carcinoma and literature review[J]. Kaohsiung J Med Sci, 2014, 30(8): 402-408.
[9]
Cheng X, Gan W, Zhang G, et al. Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies[J]. BMC Urol, 2016, 16(1): 40.
[10]
瞿元元,张海梁,叶定伟, 等. Xp 11.2易位/TFE3基因融合相关性肾癌的临床病理特征分析[J]. 中华泌尿外科杂志, 2014, 35(9): 641-644.
[11]
Kato H, Kanematsu M, Yokoi S, et al. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: radiological findings mimicking papillary subtype[J]. J Magn Reson Imaging, 2011, 33(1): 217-220.
[12]
徐晓晨,甘卫东,李笑弓等. Xp11.2易位/TFE3基因融合相关性肾癌与肾透明细胞癌的螺旋CT诊断鉴别[J]. 现代泌尿外科杂志, 2012, 17(2): 122-124.
[13]
Wang W, Ding JH, Li Y, et al. Magnetic resonance imaging and computed tomography characteristics of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion[J]. Plos One, 2014, 9(6): e99990 1-9.
[14]
van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, et al. Position paper: rationale for the treatment of Wilms tumor in the UMBRELLA SIOP-RTSG 2016 protocol[J]. Nat Rev Urol. 2017, 14(12): 743-752.
[15]
Cost NG, Geller JI, DeFoor WR, et al. A robotic-assisted laparoscopic approach for pediatric renal cell carcinoma allows for both nephron-sparing surgery and extended lymph node dissection[J]. J Pediatr Surg, 2012, 47(10): 1946-1950.
[16]
Blanc T, Pio L, Clermidi P, et al. Robotic-assisted laparoscopic management of renal tumors in children: Preliminary results[J]. Pediatr Blood Cancer. 2019, 66(Suppl. 3): e27867.
[17]
Sausville JE, Hernandez DJ, Argani P, et al. Pediatric renal cell carcinoma[J]. J Pediatr Urol, 2009, 5(4): 308-314.
[18]
Burnand K, Roberts A, Bouty A, et al. Laparoscopic nephrectomy for Wilms' tumor: can we expand on the current SIOP criteria?[J]. J Pediatr Urol, 2018, 14(3): 253. e1-253.e8.
[19]
Crispen PL, Breau RH, Allmer C, et al. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates[J]. Eur Urol, 2011, 59(1): 18-23.
[20]
Thiery M. Hermann J. Pfannenstiel (1862-1909) and the Pfannenstiel incision[J]. Gynecol Surg, 2010, 7(1): 93-95.
[21]
Strub T, Giuliano S, Ye T, et al. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma[J]. Oncogene, 2011, 30(20): 2319-2332.
[22]
Ellis CL, Eble JN, Subhawong AP, et al. Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage[J]. Mod Pathol, 2014, 27(6): 875-886.
[23]
Malouf GG, Camparo P, Oudard S, et al. Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network[J]. Ann Oncol, 2010, 21(9): 1834-1838.
[24]
Ahluwalia P, Nair B, Kumar G. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: a rare case report with review of the literature[J]. Case Rep Urol, 2013, 2013: 810590.
[25]
Kuroda N, Mikami S, Pan CC, et al. Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect[J]. Histol Histopathol, 2012, 27(2): 133-140.
[26]
Geller JI, Dome JS. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma[J]. Cancer, 2004, 101(7): 1575-1583.
[1] 张璇, 马宇童, 苗玉倩, 张云, 吴士文, 党晓楚, 陈颖颖, 钟兆明, 王雪娟, 胡淼, 孙岩峰, 马秀珠, 吕发勤, 寇海燕. 超声对Duchenne肌营养不良儿童膈肌功能的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1068-1073.
[2] 张宝富, 俞劲, 叶菁菁, 俞建根, 马晓辉, 刘喜旺. 先天性原发隔异位型肺静脉异位引流的超声心动图诊断[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1074-1080.
[3] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 939-944.
[4] 刘婷婷, 林妍冰, 汪珊, 陈幕荣, 唐子鉴, 代东伶, 夏焙. 超声衰减参数成像评价儿童代谢相关脂肪性肝病的价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 787-794.
[5] 周钰菡, 肖欢, 唐毅, 杨春江, 周娟, 朱丽容, 徐娟, 牟芳婷. 超声对儿童髋关节暂时性滑膜炎的诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 795-800.
[6] 伊喆, 王志新, 陈伟, 齐伟亚, 方杰, 石海飞, 赵夏, 赵喆, 竺枫, 盛伟, 陈焱, 张宇昊, 朱瑾, 殷耀斌, 杨勇, 陈山林, 刘波. 机器人辅助无移位急性舟骨骨折经皮内固定的诊疗与手术操作规范[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 464-468.
[7] 米洁, 陈晨, 李佳玲, 裴海娜, 张恒博, 李飞, 李东杰. 儿童头面部外伤特点分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 511-515.
[8] 罗佳, 赵晶晶, 曹小珍, 钟玲, 范林军, 曾令娟. 单侧腋窝双侧乳晕入路机器人甲状腺术后局部加压预防皮下隧道出血的对照研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 603-606.
[9] 刘成, 赖聪, 黄健, 王建辰, 罗茜芸, 许可慰. EDGE SP1000单孔手术机器人辅助腹腔镜下猪输尿管部分切除联合端端吻合术的可行性研究[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 642-646.
[10] 王蕾, 王少华, 牛海珍, 尹腾飞. 儿童腹股沟疝围手术期风险预警干预[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 768-772.
[11] 李芳, 许瑞, 李洋洋, 石秀全. 循证医学理念在儿童腹股沟疝患者中的应用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 782-786.
[12] 吕垒, 冯啸, 何凯明, 曾凯宁, 杨卿, 吕海金, 易慧敏, 易述红, 杨扬, 傅斌生. 改良金氏评分在儿童肝豆状核变性急性肝衰竭肝移植手术时机评估中价值并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 661-668.
[13] 卓少宏, 林秀玲, 周翠梅, 熊卫莲, 马兴灶. CD64指数、SAA/CRP、PCT联合检测在小儿消化道感染性疾病鉴别诊断中的应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 505-509.
[14] 刘笑笑, 张小杉, 刘群, 马岚, 段莎莎, 施依璐, 张敏洁, 王雅晳. 中国学龄前儿童先天性心脏病流行病学研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1021-1024.
[15] 李静, 张玲玲, 邢伟. 兴趣诱导理念用于小儿手术麻醉诱导前的价值及其对家属满意度的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 812-817.
阅读次数
全文


摘要